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1. Introduction 
During routine investigations on 5 3-year-old 
female, admitted to the Department of Internal Medi- 
cine at Ankara University with iron-deficiency 
anaemia, hepatosplenomegaly andcardiac omplaints, 
a fast-moving haemoglobin was noted on starch gel 
electrophoresis. The J-like haemoglobin was charac- 
terised as a2/~ 10 (A7) Ala ~ Asp and was named 
Hb Ankara. 
2. Methods 
Haemoglobin (Hb) electrophoresis was performed 
on paper in Tris buffer at pH 8.9 [1] and on starch 
gel at pH 8.6 [2]. Haemolysates were fractionated 
using column chromatography as described by Huis- 
man and Dozy [3] ; the resulting haemoglobin fractions 
were concentrated byultrafiltration at4°C and puri- 
fied by paper electrophoresis [1 ], 
Globin was prepared from purified haemoglobin 
by acid-acetone precipitation at-20°C [4], washed 
three times with cold acetone and dried in vacuo over 
P2Os. Digestion of the total globin with trypsin and 
analysis of that portion of the digest which was solu- 
ble at pH 6.4, by fingerprinting, was carried out as 
previously described [5]. The abnormal peptide from 
Hb Ankara was isolated by preparative fingerprinting 
followed by paper electrophoresis at pH 3.5 (55 V/cm 
for 2hr), located by staining with dilute (0.02%, w/v) 
ninhydrin in acetone (containing 1% v/v pyridine) and 
eluted with 0.5 N NH4OH. For amino acid composi- 
tion studies, aportion of the eluate was dried and 
hydrolysed, in a sealed tube, with constant-boiling 
HC1 for 16 hr at 108°C; after removal of excess HC1 
in a rotary evaporator, the amino acid composition of 
the dried hydrolysate was determined using a Locarte 
amino acid analyser [6]. 
The sequence of the first residues of the variant 
peptide was determined by dansyl (DNS)-Edman 
degradation; the Edman procedure was that 
described by Gray [7] and dansylation was per- 
formed according to Brown and Perham [8]. DNS- 
peptides were hydrolysed for 4 hr at 108°C in 6 N 
HC1 [9] and DNS-amino acids were identified by 
chromatography on polyamide thin layers [10]. 
3. Results 
On paper electrophoresis at pH 8.9, the patient's 
haemolysate showed three fractions, namely [1 ] Hb A 
[2] a poorly-resolved band moving more rapidly 
towards the anode, in the position of Hb J and [3] a 
single Hb A. Column chromatography resolved the 
North-Holland Publishing Company - Amsterdam 121 
Volume 42, number 2 FEBS LETTERS June 1974 
Hb. J 
e 
trace of~ATp-- II 




- -<  pH 6 .4  . . . . . .  "1- 
Fig. 1. Fingerprint of the soluble tryptic peptides of Hb Ankara. Electrophoresis atpH 6.4, 53 V/cm for 1 hr. Ascending chroma- 
tography in pyridine-isoamyl alcohol-water (6:6: 7, by voL) for 19 hr. Peptides located by staining with 0.2% (w/v) ninhydrin 
in acetone containing 1% (v/v) pyridine. 
* = origin. 
haemolysate into 3% Hb A2, 55% Hb A + Aa and 
42% Hb J + Ja. Even after further purification by 
paper electrophoresis the Hb J fraction was seen, on 
fingerprinting, to still contain some Hb Aa. 
Comparison of the fingerprint obtained from the 
variant haemoglobin with the pattern produced by 
Hb A (fig. 1) indicated that the positively-charged 
peptide/3TplI (residues/39-17), which normally gives 
a staining reaction for tryptophan, was very much re- 
duced in amount and that there was present a new 
tryptophanpositive p ptide, overlapping/3ATplX, in
the neutral region. Both peptides gave a transient 
brown colour on staining with ninhydrin, indicative 
of N-terminal serine; the/3ATplI present on the finger- 
print was probably derived from Hb Aa. 
Amino acid analysis of the variant peptide showed 
its amino acid composition (table 1) to resemble that 
of/3ATplI except hat one of the two residues of ala- 
nine (/310 or/313) normally found in this peptide 
(see fig. 2) had been replaced by a residue of aspartic 
acid. Asparagine also appears as aspartic acid on amino 
acid analysis after acid hydrolysis, but an alanine to 
asparagine substitution, which in any case could not 
arise from a single point mutation, could be eliminated 
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on the basis of the electrophoretic mobility of both 
the variant haemoglobin and peptide. Dansyl-Edman 
degradation of the peptide/3JTplI showed that alanine 
/310 had been replaced by aspartic acid, making it clear 
Table 1 
Amino acid composition of peptide #TplI from 
Hb Ankara 
Amino acid Hb Ankara Expected for 
HbA 
Asp 0. 9 - 
Thr 1.0 1 
Ser 1.0 1 
Gly 1.0 1 
Ala 1.1 2 
Val 1.0 1 
Leu 1.1 1 
Lys 1.0 1 
Trp + + 
One amino acid residue is approximately 31 nmoles. 
+ Indicates apositive staining reaction for tryptophan (which 
is destroyed during the hydrolysis with HCI preceding 
amino acid analysis). 
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Residue No. 9 10 11 12 13 14 15 16 17 
Helical No. A6 A7 A8 A9 A10 A l l  A12 A13 A14 
Residues 
Hb A Ser Ala Val Thr Ala Leu Trp Gly Lys 
Hb Ankara Ser ASP Val Thr Ala Leu Trp Gly Lys 
Fig. 2. Amino acid sequence of the tryptic peptide/3TpII from Haemoglobins A and Ankara 
that the substitution in Hb Ankara is/~10 (A7) Ala 
Asp, a mutation which has not been reported pre- 
viously. 
Generally speaking, substitution of amino acids at 
sites which are external in the haemoglobin quater- 
nary structure do not grossly affect the properties of 
the tetramer [11 ]. The substitution in Hb Ankara is 
at an external site, which therefore plays no part in 
subunit contacts or haem binding; in view of the fact 
that the relative proportion of the variant haemoglobin 
was approximately that for a normal, stable/~-chain 
variant, it seems unlikely that the presence of Hb 
Ankara in the erythrocytes of this patient would have 
contributed to her anaemia. Unfortunately, no de- 
tailed clinical and haematological data were available 
to assess the likely cause of  anaemia nd none of the 
patient's family was examined. 
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